From the Center for Medical Genetics, University Hospital Ghent, Belgium; Laboratory for Leukemia Diagnostics, University Hospital Grosshadern, Ludwig-Maximilians-University of Munich, München, Germany; Department of Molecular Medicine, Karolinska Hospital and Institute, Stockholm, Sweden; Division of Hematology and Oncology, Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus; Departments of Clinical Genetics/Cell Biology and Genetics, Erasmus MC, Rotterdam, The Netherlands; Department of Hematology and Center for Human Genetics, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Department of Human Genetics, CHU Sart Tilman, Liège, Belgium; Laboratoire d'Hématologie, CHU Toulouse, France; Centre for Human Genetics, University of Leuven, Belgium.
MLL amplification was recently recognized as a recurrent aberration in acute myeloid leukemia (AML) and myelodys-plastic syndrome (MDS), associated with adverse prognosis and karyotype complexity. Here we present detailed results of fluorescence in situ hybridization (FISH) and expression analyses of MLL and 5 selected 11q candidate oncogenes (CBL, DDX6, ETS1, FLI1, and PLZF) in 31 patient samples and one cell line with 11q23 gain. FISH analyses revealed that the 11q23 amplicon invariably encompassed MLL, DDX6, ETS1, and FLI1, whereas expression analyses identified MLL and DDX6 as the most differentially expressed genes among samples with and without 11q23 copy gain or amplification. In MLL-amplified samples, a significant transcriptional up-regulation of MEIS1, PROML1, ADAM10, NKG2D, and ITPA was noted. Further analyses, designed to elucidate a possible role of the 11q overexpressed genes (MLL, DDX6, FLI1, and ETS1) in unselected MDS and AML samples, revealed a significant upregulation of MLL in MDS. Our findings confirm the MLL gene as a prominent target of 11q23 amplification and provide further evidence for an etiologic role for MLL gain of function in myeloid malignancies. In addition, our results indicate that the transcriptional program associated with MLL rearrangements and MLL overexpression displays significant similarities.
Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs
Cardiac-Specific Overexpression of Diacylglycerol Kinase Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice
CD8+ T Lymphocytes Regulate the Arteriogenic Response to Ischemia by Infiltrating the Site of Collateral Vessel Development and Recruiting CD4+ Mononuclear Cells Through the Expression of Interleukin-
Altered Expression of Disintegrin Metalloproteinases and Their Inhibitor in Human Dilated Cardiomyopathy
Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy
Decreased Neurotrophin TrkB Receptor Expression Reduces Lesion Size in the Apolipoprotein E–Null Mutant Mouse
Nox1 Overexpression Potentiates Angiotensin II-Induced Hypertension and Vascular Smooth Muscle Hypertrophy in Transgenic Mice
Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression
Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease
Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria